named programs · 3 · from sources
What they call their work
GP-write Conference Series
Annual scientific meeting bringing together researchers, ethicists, and industry partners to present advances in genome engineering and coordinate collaborative projects
GP-write Technology Effort (GPW Hub)
Development of computer-aided design (CAD) tools and foundational technologies for large-scale genome synthesis and editing in human and other species
Ultra-safe Cells Project
International research initiative to engineer human cells resistant to viruses, cancer, and aging through genome recoding, requiring over 400,000 changes to the human genome
activities · 4 groups
What they do
-
Biomedical Research and Innovation 1 activity
- Conducts research in genome-scale engineering and synthetic biologyLeads and supports research initiatives in large-scale genome synthesis, editing, and artificial genome development, including efforts to engineer ultra-safe, virus-resistant human cells and to improve the speed and cost-efficiency of genome writing technologies. The organization has published official GP-write papers and meeting summaries, and secured over $232 million in related funding across institutions.
-
-
Genetic and Neurological Disease Research Funding 1 activity
- Funds translational research and biotech startups in genome engineeringProvides up to $500,000 in direct funding, scientific oversight, and advising to biotech startups and translational research projects, including a specific initiative to develop gene-editing treatments for Charcot Marie Tooth Disease Type 4B3.
-
-
Scientific Conference & Symposium Management 1 activity
- Hosts scientific conferences and meetings for genome engineering expertsOrganizes and hosts annual GP-write conferences and scientific working meetings, including virtual and in-person events with poster sessions, press briefings, and receptions, convening hundreds of experts in genome editing, synthesis, and DNA assembly technologies. Examples include the GP-write 5.0 meeting in October 2021 and the 2018 Scientific Working Meeting at Harvard Medical School.
-
-
Uncategorized 2 activities
- Builds collaborative research infrastructure and consortium networksCoordinates and expands a global consortium of researchers and institutions through working groups, industry advisory boards, and pilot projects. Activities include forming 10 working groups with monthly meetings, launching 26 pilot projects, establishing partnerships with industry, and organizing roadmap development efforts for the GP-write initiative.
- Develops Computer-Aided Design (CAD) platforms for whole genome designDevelops foundational CAD technology for genome-scale writing in collaboration with Lattice Automation, aiming to enable the design and construction of entire genomes through software tools. This includes launching the first phase of a GP-write CAD platform to support large-scale genome synthesis and editing.
-
financials · form 990EZ · fy2024
revenue
Total revenue$12
Contributions & grants$00%
Program service revenue$12100%
Investment income——
Other revenue—
expenses
Total expenses$29K
Program expenses—
Admin / overhead—
Fundraising—
Salaries & benefits—
Grants paid out—
balance sheet
Total assets$157K
Cash—
Investments—
Liabilities—
Net assets$157K
4 years on record · 2020–2024 · YoY revenue -25.0%
leadership · form 990 part vii · fy2024
Who runs it
board members · 3
- AMY SCHWARTZ — PRESIDENT / DIRECTOR
- FARREN ISAACS — DIRECTOR
- GEORGE CHURCH — DIRECTOR
relationships · 22
Who they work with
- Agilent Partner — Member of the Industry Advisory Board and collaborator in building a team of industry leaders.
- CATALOG dna Partner — Featured partner of GP-write in DNA-based technology development.
- Cellectis Partner — Published a book titled “Editing Life: Faces Behind the Gene Editing Revolution,” with proceeds donated to GP-write.
- GP-write Network — Hosted the GP-write Conference 5.0, indicating active participation in the GP-write network
- Genome Project-write Partner — GP-write is a collaborative scientific initiative coordinated by the Center of Excellence for Engineering Biology to advance large-scale genome engineering.
- Harvard Medical School Partner — Hosted the GP-write Scientific Working Meeting at the Joseph P Martin Conference Center.
- Harvard Medical School Partner — Hosted the GP-write meeting in May 2018.
- IndieBio Partner — Featured partner of GP-write in engineering biology innovation.
- Inscripta Partner — Megabase sponsor of the GP-write 5.0 meeting
- Labcyte Partner — Collaborates with Labcyte to advance engineering biology through innovative liquid-handling technologies.
- Lattice Automation Partner — Collaborating on the development of the GP-write Computer-Aided Design Platform for whole genome design.
- Lattice Automation Partner — Megabase sponsor of the GP-write 5.0 meeting
- Moderna Partner — Industry partner enabling cutting-edge research for GPW affiliates.
- NYU Langone Medical Center Partner — Collaborates through the involvement of Jef Boeke, director of the Institute for Systems Genetics at NYU Langone, whose Sc2.0 yeast genome project serves as a model for GP-write.
- New York University Partner — Hosted the 2019 GP-write meeting in November.
- SIAT Partner — Hosting the next in-person/virtual GP-write meeting in Shenzhen, China.
- Synthorx Partner — Industry partner enabling cutting-edge research for GPW affiliates.
- Twist Biosciences Partner — Industry partner enabling cutting-edge research for GPW affiliates.
- Wyss Institute at Harvard University Partner — Collaborates through the involvement of George Church, a founding core faculty member at the Wyss Institute and a key participant in GP-write.
- biotech founders Partner — Provides advising and oversight to funded startups
- engineeringbiologycenter.org Network — Hosts GP-write consortium activities and resources
- world-class scientists Partner — Provides advising and oversight to funded startups
strategies · 4
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Consortium-Based Collaborative Innovationmethodology: consortium-based research collaborationBy building international research consortia with active working groups and pilot projects, the organization accelerates progress on grand challenges in engineering biology, because large-scale, coordinated collaboration across institutions and disciplines enables shared infrastructure, standards, and knowledge that individual labs cannot achieve alone.
- Genome Writing and Foundry-Driven Engineeringmethodology: genome-writingBy shifting from reading to writing DNA and using integrated biofoundry platforms, the organization enables large-scale genome design and engineering to solve global challenges in science and medicine, because automated, industrialized biological design accelerates innovation and translation.
- Integrated Research-Education-Ethics Modelmethodology: responsible-research-and-innovationBy combining research, education, and ethical oversight in genome engineering, the organization ensures responsible innovation and broader societal impact, because embedding ethics and training into technical development fosters sustainable, equitable, and policy-informed scientific progress.
- Startup Acceleration through Non-Dilutive Supportmethodology: startup_acceleration_through_funding_and_expert_guidanceBy providing non-dilutive funding, expert advising, and scientific oversight to early-stage biotech startups, the organization de-risks translational development in genome engineering, because access to capital and technical mentorship enables founders to advance high-potential ideas without premature commercial pressure.